Gastro-oesophageal reflux disease
Clinical criteria:
The treatment must be for long-term maintenance of gastro-oesophageal reflux disease in a patient with symptoms inadequately controlled using a low dose proton pump inhibitor.
Pharmaceutical benefits that have the forms omeprazole tablet 20 mg, omeprazole capsule 20 mg and omeprazole tablet 20 mg (as magnesium) are equivalent for the purposes of substitution.
Check patient adherence to lower dose proton pump inhibitor before "stepping-up" therapy.
Low dose proton pump inhibitors are appropriate step-down therapy from standard dose proton pump inhibitors.
A low dose proton pump inhibitor includes: lansoprazole 15mg, omeprazole 10mg, pantoprazole 20mg and rabeprazole 10mg.
No increase in the maximum quantity or number of units may be authorised.
No increase in the maximum number of repeats may be authorised.